Even when scientists reach a breakthrough, they need partners to help translate discoveries into therapeutics or diagnostics for wide use in clinical settings. The work is a team sport, and it functions most efficiently and effectively when the baton moves smoothly from one expert to the next.

"By funding centers around people like Beth Stutzmann and Michelle Hastings, the research park will make this transfer to market faster and more symbiotic," Dr. Kaplan said, referencing RFU scientists doing groundbreaking research in Alzheimer’s and degenerative diseases, respectively.